Researchers move closer to a functional cure for chronic hepatitis B

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

Biocytogen, Radiance partner for bispecific antibody-drug conjugate

Share this article The partnership aims to advance the development of a first-in-class fully human anti-HER2/TROP2 BsADC for cancer treatments. Credit: Spectral-Design/shutterstock.com. Biocytogen Pharmaceuticals and

January 9, 2024

Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Dexcom has invested $75 million

November 20, 2024

U.S. Deaths Are Down and Life Expectancy Is Up, but Improvements Are Slowing

U.S. life expectancy jumped last year, and preliminary data suggest there may be another — much smaller — improvement this year. Death rates fell last

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.